Key Takeaways:

• Retinoid selection should match performance and tolerance goals. Use the conversion ladder and format needs to choose between retinyl esters, retinol, retinal, and HPR.
• Stability is engineered across the full system—not just the ingredient. Control light, oxygen, and heat with the right antioxidant/chelating strategy, pH management, processing controls, and protective packaging.
• Delivery format drives both efficacy and irritation. Anhydrous systems, O/W emulsions, and water-dispersible bases each require different protection strategies; encapsulation/controlled release can improve stability and tolerability.
• Compatibility matters as much as concentration. Pair retinoids with barrier-supporting co-actives (ceramides, niacinamide, humectants, soothing agents) and avoid high-risk combinations that increase oxidation or irritation (e.g., benzoyl peroxide, strong exfoliant stacking).
• Potency claims require data-backed validation. Use accelerated and real-time stability, packaging compatibility testing, and assay-based potency tracking to support shelf life and scale-up decisions.

Retinoids are among the most clinically validated cosmetic actives, valued for improving texture, supporting collagen, and targeting visible signs of aging and uneven tone.¹ However, successful retinoid formulation is rarely about which active is “strongest”—it is defined by whether that active can survive light, oxygen, and heat while remaining tolerable on the skin.

This guide is designed for R&D chemists, formulation scientists, and product development teams who want to build retinoid products that are not only effective on paper, but stable, scalable, and claim-supportable in-market. We’ll move from retinoid selection (retinol, retinal, hydroxypinacolone retinoate/HPR, and retinyl esters) into a stability-first formulation strategy—covering degradation triggers, what failure looks like during stability, delivery system choices, compatibility screening, and the testing required to validate potency over shelf life.

Retinoids 101 for Formulators

Retinoids stimulate skin renewal and boost collagen production, making them essential for anti-aging and reparative skincare formulations.^1,2 Despite their benefits, formulators must address several challenges:

• Sensitivity to environmental factors (such as light, air, and heat) that can degrade the active ingredients³
• The risk of irritation, where higher concentrations may induce redness, flaking, and dryness⁴
• Variability in potency and stability among different retinoid types, necessitating careful ingredient selection and process optimization.

To harness the full potential of cosmetic actives like retinoids, it is critical to balance efficacy with stability while minimizing irritation through smart formulation design.

The Role of Retinoids in Skincare

Retinoids offer several key skin benefits:

• Accelerated cell turnover for smoother, more youthful skin⁵
• Enhanced collagen synthesis to reduce fine lines and improve firmness²
• Targeted treatment for aging, uneven tone, and acne⁶
• Synergistic formulation opportunities when combined with complementary actives such as peptides, niacinamide, and ceramides.

The Retinoid Conversion Ladder and Performance/Irritation Spectrum

Most retinoids require conversion into their active form, retinoic acid, to deliver the desired effects. Compounds requiring fewer conversion steps tend to act faster but may also increase the risk of irritation.⁷

• Retinyl Esters (e.g., retinyl palmitate, retinyl acetate): These are the most stable and gentle forms that require multiple metabolic steps to convert into retinoic acid.⁸ While ideal for sensitive skin formulations, their optimal usage concentrations are often formulation-specific and determined by the product’s design.
• Retinol: Requires two conversion steps and strikes a balance between efficacy and market familiarity.⁷ It is moderately potent but more vulnerable to degradation and irritation at higher doses. Formulations typically contain retinol in the range of 0.2% to 1%.⁹
• Retinal (Retinaldehyde): Needing only one conversion step, retinal can deliver results more rapidly; however, it is less stable than retinol.¹⁰ Many formulations use concentrations generally around 0.05% to 0.1% to balance potency and stability.¹¹
• Hydroxypinacolone Retinoate (HPR): This retinoid binds directly to retinoid receptors without conversion.¹² It is recognized for its high efficacy and improved stability relative to retinol, although established concentration ranges are less clearly defined in literature and tend to be optimized per formulation.

The next step is to carefully select the appropriate retinoid based on formulation needs. This choice should align with desired potency, skin tolerance, and product format.

Retinol vs. Retinal vs. HPR vs. Retinyl Esters: Choosing the Right Retinoid

Below is a decision matrix summarizing key aspects of each retinoid type. Note that while concentration ranges for retinol and retinal are supported by current formulation practices, the optimal usage levels for retinyl esters and HPR are typically defined by specific formulation requirements rather than fixed percentage ranges.

Retinoid Type	Potency	Irritation Potential	Stability	Ideal Formats	Usage Range
Retinyl Esters	Lower potency	Very low	High	Moisturizers, gentle serums	Formulation-dependent (generally low levels)
Retinol	Moderate to High	Moderate to High	Moderate	Creams, night oils, serums	Approximately 0.2% – 1%9
Retinal (Retinaldehyde)	High	High	Less stable	Serums, anhydrous or well-protected products	Generally around 0.05% – 0.1%11
HPR	High	Moderate	More stable than retinol	Advanced serums, emulsions and novel formulations	Concentration varies; use as directed by testing

When selecting a retinoid, consider product goals and target consumer skin sensitivity. Retinyl esters suit sensitive or introductory products, while retinal and HPR align with advanced, performance-driven formulas.

Tackling Stability: Overcoming Retinoids’ Biggest Formulation Hurdle

Ensuring retinoids remain effective throughout the product’s lifecycle is one of the greatest formulation challenges. Their susceptibility to degradation from light, oxygen, and heat must be tackled holistically.³

Main Stability Challenges and What Degradation Looks Like

Retinoids are highly sensitive to light, oxygen, and heat. When instability begins, it often shows up first as sensory drift—then as measurable potency loss.

• Photodegradation (light exposure): rapid loss of activity, often accompanied by color shift/yellowing over time.¹³
• Oxidation (air exposure): odor development (oxidized/stale notes), assay drift/potency loss, and in oil phases rising peroxide values.¹⁴
• Heat sensitivity (elevated temperatures): accelerated breakdown that can present as faster potency loss plus viscosity drift, haze, or phase instability during heat cycling.³
• System/packaging interactions (materials and delivery): discoloration or softening of components, leaking, loss of airless performance, and increased oxygen exposure that compounds degradation.

The Stability Triangle: Formula, Process, and Packaging

To combat these challenges, consider the following strategies:

Optimizing Formula Composition

• Incorporate antioxidants (such as vitamin E or ascorbyl compounds) to neutralize free radicals and protect retinoid integrity.¹⁵ 
• Maintain an optimal pH—preferably moderately acidic to neutral—to support retinoid stability.¹⁶ 
• Reduce water content with anhydrous or low-water approaches to limit hydrolysis.¹⁷ 
• Use encapsulation methods to create a protective barrier against environmental stressors.¹⁸

Refining Manufacturing Processes

• Manage temperatures rigorously during mixing to prevent heat-induced degradation.
• Utilize inert gas environments or nitrogen overlays to restrict oxygen exposure.
• Streamline processing times to minimize exposure to degrading factors.

Protective Packaging Techniques

• Choose airless and opaque containers that minimize exposure to air and light.
• Use dark glass bottles and packaging with minimal headspace to reduce oxygen contact.

Practical stability tips include running robust simulated stability tests, incorporating pH buffers, and using co-stabilizers to maintain retinoid integrity.

Delivery Systems: Maximizing Retinoid Performance in Formulations

The delivery mechanism plays a pivotal role in preserving retinoid activity and ensuring optimal skin penetration. Selecting the right delivery system enhances both stability and consumer satisfaction.

Comparing Delivery Formats

• Anhydrous Systems: Eliminates water, reducing the risk of hydrolysis and oxidation.¹⁷ Often results in a richer, oil-based formulation that may suit only specific product types.
• Oil-in-Water (O/W) Emulsions: Offers familiar, consumer-friendly textures found in creams and lotions. Requires additional stabilization to counteract water-related degradation.
• Water-Dispersible Systems: Provides lightweight, refreshing textures ideal for modern serums. May need extra protection to preserve retinoid integrity.

Advanced Delivery Technologies

To further enhance performance:

• Employ encapsulation or liposomal delivery to shield the active ingredient and improve penetration^18,19
• Incorporate controlled-release systems, minimizing irritation by gradually releasing the active over time.²⁰

A thoughtful balance of sensory properties and protective measures ensures that the delivery system not only maintains retinoid stability but also enhances overall consumer experience.

Compatible Co-Actives and Incompatibilities

Retinoids can be optimized significantly when paired with supportive co-actives that reinforce barrier function, reduce irritation risk, and limit oxidation pathways. At the same time, certain combinations—either within the same formula or within the same routine—can compromise stability and/or tolerability. Use the guidance below to design resilient, high-performance systems.

Compatible Co-Actives

Barrier and Tolerability Support

• Ceramides, cholesterol, fatty acids: Strengthen barrier lipids and help offset dryness and flaking associated with retinoid use.²¹
• Niacinamide: Supports barrier function and can improve overall tolerability in leave-on retinoid systems.²²
• Soothing agents (panthenol, bisabolol, allantoin, beta-glucan): Reduce irritation signals and improve user adherence, especially in higher-potency tiers.²³
• Humectants (glycerin, hyaluronic acid, sodium PCA): Provide hydration support to improve sensory profile and reduce perceived dryness.²⁴

Stability-Supporting Components

• Antioxidants (tocopherol, selected ascorbyl derivatives): Help mitigate oxidative stress within the formula (select based on phase solubility and system design).¹⁵
• Chelators (e.g., EDTA, sodium phytate): Bind trace metals that can catalyze oxidation and accelerate retinoid degradation.²⁵
• Encapsulation / controlled-release systems: Provide a protective barrier against oxygen/light exposure and can reduce irritation by moderating delivery.^18,20

Performance Synergy Opportunities

• Peptides: Complement retinoid positioning for visible firming and line-reduction claims without introducing common stability conflicts.²⁶
• Brightening and tone-support ingredients (system-dependent): Can enhance radiance/tone outcomes when irritation risk is managed and compatibility is validated through testing.

Incompatibilities and Caution Zones

High-Risk Oxidative Conflicts

• Benzoyl peroxide: Strong oxidizing environments can compromise retinoid integrity.²⁷ If both are required in a regimen, separate usage instructions (e.g., alternating nights) and validate with potency testing.
• Peroxide-prone or highly unsaturated oils: Increase oxidation pressure and can contribute to odor/color drift over shelf life; select stable oils and confirm via accelerated and real-time studies.

Irritation Stacking

• Strong exfoliant systems (high AHA/BHA load) paired with retinoids: Can significantly increase erythema, dryness, and flaking.²⁸ If both are desired, consider spacing strategies, controlled-release, and clear onboarding instructions.
• High-fragrance or allergen-heavy systems: Can confound irritation attribution and increase sensitivity outcomes—particularly in advanced retinoid tiers.

System and Packaging Constraints

• Clear packaging, non-airless delivery, high headspace: Increases light/oxygen exposure and can reduce potency retention; prioritize opaque and air-restrictive systems.
• Uncontrolled heat and oxygen exposure during processing/filling: Increases degradation risk; define temperature limits, hold times, and oxygen-minimizing practices in SOPs.

Quality, Testing, and Specifications: Ensuring Success Before Scaling

Before scaling production, rigorous testing and quality assurance measures are essential to ensure both product consistency and optimal performance in real-world conditions.

Essential Supplier Documentation

Ensure comprehensive documentation, including:

• Purity and ingredient identification certificates from third-party labs
• Detailed degradation and stability profiles
• Handling and storage guidelines to maintain active integrity
• Regulatory compliance documentation in line with global cosmetic standards.

In-House Testing Protocols

Perform systematic tests to validate your formulation:

1. Accelerated Stability Studies: Test under elevated temperature and humidity conditions.
2. Real-Time Stability Monitoring: Verify product performance under regular storage conditions.
3. Packaging Compatibility Tests: Ensure that chosen packaging protects retinoid activity.
4. Sensory Evaluations: Confirm consistency in texture, appearance, and efficacy over time.

Best Practices to Prevent Formulation Failures

• Optimize active concentrations to minimize irritation and instability.
• Simulate distribution conditions to anticipate and mitigate transport stresses.
• Standardize testing methods to generate reliable data for iterative adjustment.

Building a Retinoid Routine as a Product Line

Developing a comprehensive retinoid-based product line allows brands to address varying consumer needs from beginners to experienced users. A progressive, tiered system builds tolerance while consistently delivering targeted benefits.

• Beginner-Friendly Formulations: Utilize retinyl esters or low-level retinol in hydrating lotions and introductory night creams.
• Intermediate Products: Offer lightweight serums or emulsions containing moderate-strength retinol or carefully optimized levels of advanced actives.
• Advanced Treatments: Develop concentrated formulas with retinal or HPR for experienced users who have built up skin tolerance.

Clear and precise usage instructions are essential to build consumer confidence and promote safe, gradual incorporation of retinoids into a skincare routine.

Regulatory and Distribution Reality Check

To protect retinoid potency from lab to consumer, build regulatory and distribution constraints into development—not after scale-up:

• Confirm regional rules early (INCI naming, claim language, and any retinoid-related restrictions) and align label directions/warnings with intended markets.
• Lock supplier documentation for every lot: CoA, impurities profile, residual solvents, stability data, and recommended processing/storage conditions.
• Set distribution stress targets and test them: temperature excursions, light exposure, vibration, and freeze–thaw aligned to your actual lanes (air/sea/ground).
• Validate packaging under transport (airless performance, oxygen ingress, UV protection, headspace control, compatibility/leachables).
• Define shelf-life by data, using real-time and accelerated stability with assay-based retinoid potency (not appearance-only).
• Standardize storage and handling SOPs across manufacturing, filling, and warehousing (nitrogen overlay, max hold times, temperature limits).
• Create a deviation playbook for excursions (quarantine criteria, retest plan, potency thresholds, release decision tree).

FAQ: Retinoid Formulation, Stability, and Compatibility

Is retinaldehyde (retinal) less stable than retinol?

In many formulation contexts, retinal is more reactive and can be harder to protect than retinol, particularly around oxygen exposure and pH drift.¹⁰ If you choose retinal for faster performance, plan for a tighter stabilization strategy: oxygen control (process and packaging), robust antioxidant/chelating support where appropriate, and early packaging compatibility screening.

Does airless packaging really improve retinoid stability?

Yes—airless, opaque systems are often one of the highest-impact stability levers because they reduce oxygen exposure and light-driven degradation during consumer use.²⁹ The key is validation: confirm oxygen/light protection, pump performance over time, and material compatibility (seals, wipers, elastomers). Packaging is part of the stability system, not an afterthought.

Encapsulated vs. free retinol: what changes in formulation and testing?

Encapsulation can improve stability and tolerability by physically protecting retinol and moderating release, but it also changes dispersion, processing sensitivity, and analytical strategy.¹⁸ You’ll typically need to confirm capsule integrity after manufacturing, verify uniformity, and ensure your potency method can accurately quantify active in the finished matrix (not just “looks stable” checks).

Can you combine retinoids with AHAs/BHAs in the same product?

It depends on the system. Combining strong exfoliating acids with retinoids can increase irritation risk and complicate stability (especially if the final pH is driven low).²⁸ Many brands separate these into different products or usage schedules. If combined, consider controlled-release approaches, barrier-supportive co-actives, and confirm tolerability and potency retention with testing.

Can you combine retinoids with benzoyl peroxide?

Benzoyl peroxide is a strong oxidizer and can compromise retinoid integrity, making it a common “compatibility fail” either in-formula or in consumer layering.²⁷ When both are needed for an acne regimen, a practical strategy is to separate them by routine timing (e.g., alternate nights) and validate performance with potency and stability data.

What are the earliest warning signs a retinoid formula is failing?

The first signals are often subtle: gradual color shift/yellowing, odor changes, and small viscosity or clarity drift—especially under heat/light stress.^13,14 The critical point is that appearance can lag behind chemistry. Track assay potency across timepoints, monitor peroxide values where relevant, and treat sensory drift as a trigger for deeper investigation.

How do you choose between retinol, retinal, HPR, and retinyl esters?

Start with your performance target, tolerance profile, and format constraints. Retinyl esters fit gentle, introductory products; retinol balances familiarity and performance but needs strong stabilization; retinal offers faster results but typically demands tighter control¹⁰; HPR can support advanced positioning with potentially improved stability, but usage levels and performance should be proven through your own testing.¹²

A Practical Retinoid Formulation Framework

Retinoids remain some of the most valuable cosmetic actives—but consistent, market-ready performance is only achievable when selection, stabilization, delivery, and validation are designed as one integrated system. Start by choosing the right retinoid for the target consumer and product format, then protect potency through a stability-first approach that accounts for formula composition, manufacturing controls, and air- and light-restrictive packaging. Finally, confirm real-world success with assay-based potency tracking, packaging compatibility, and distribution-relevant stress testing.

If you’re developing a retinoid product and want to reduce stability risk, shorten iteration cycles, or validate a claim-ready system, connect with the Vivify Beauty Care technical team. Share your target format, retinoid type, and performance goals, and we’ll help you identify the most effective stabilization and delivery approach—plus the testing plan needed to support launch and scale with confidence.

References

1. Mukherjee, S., Date, A., Patravale, V., Korting, H. C., Roeder, A., & Weindl, G. (2006). Retinoids in the treatment of skin aging: An overview of clinical efficacy and safety. Clinical Interventions in Aging, 1(4), 327–348. https://doi.org/10.2147/ciia.2006.1.4.327
2. Varani, J., Warner, R. L., Gharaee-Kermani, M., Phan, S. H., Kang, S., Chung, J. H., Wang, Z. Q., Datta, S. C., Fisher, G. J., & Voorhees, J. J. (2000). Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. Journal of Investigative Dermatology, 114(3), 480–486. https://doi.org/10.1046/j.1523-1747.2000.00902.x
3. Brisaert, M., Plaizier-Vercammen, J. (2000). Investigation on the photostability of a tretinoin lotion and stabilization with additives. International Journal of Pharmaceutics, 199(1), 49–57. https://doi.org/10.1016/S0378-5173(00)00357-6
4. Leyden, J. J., Grove, G. L., Grove, M. J., Thorne, E. G., & Lufrano, L. (1989). Treatment of photodamaged facial skin with topical tretinoin. Journal of the American Academy of Dermatology, 21(3 Pt 2), 638–644. https://doi.org/10.1016/s0190-9622(89)70234-7
5. Kafi, R., Kwak, H. S., Schumacher, W. E., Cho, S., Hanft, V. N., Hamilton, T. A., King, A. L., Neal, J. D., Varani, J., Fisher, G. J., Voorhees, J. J., & Kang, S. (2007). Improvement of naturally aged skin with vitamin A (retinol). Archives of Dermatology, 143(5), 606–612. https://doi.org/10.1001/archderm.143.5.606
6. Orfanos, C. E., Zouboulis, C. C., Almond-Roesler, B., & Geilen, C. C. (1997). Current use and future potential role of retinoids in dermatology. Drugs, 53(3), 358–388. https://doi.org/10.2165/00003495-199753030-00003
7. Roos, T. C., Jugert, F. K., Merk, H. F., & Bickers, D. R. (1998). Retinoid metabolism in the skin. Pharmacological Reviews, 50(2), 315–333. https://pubmed.ncbi.nlm.nih.gov/9647870/
8. Antille, C., Tran, C., Sorg, O., Carraux, P., Didierjean, L., & Saurat, J. H. (2003). Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation. Journal of Investigative Dermatology, 121(5), 1163–1167. https://doi.org/10.1046/j.1523-1747.2003.12519.x
9. Babamiri, K., & Nassab, R. (2010). Cosmeceuticals: The evidence behind the retinoids. Aesthetic Surgery Journal, 30(1), 74–77. https://doi.org/10.1177/1090820X09360704
10. Saurat, J. H. (1999). Retinaldehyde: from basic science to clinical applications in dermatology. Journal of the American Academy of Dermatology, 40(6 Pt 2), S3–S5. https://pubmed.ncbi.nlm.nih.gov/10336916/
11. Creidi, P., Vienne, M. P., Ochonisky, S., Lauze, C., Turlier, V., Lagarde, J. M., & Dupuy, P. (1998). Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. Journal of the American Academy of Dermatology, 39(6), 960–965. https://doi.org/10.1016/s0190-9622(98)70270-1
12. Zasada, M., & Budzisz, E. (2019). Retinoids: Active molecules influencing skin structure formation in cosmetic and dermatological treatments. Postępy Dermatologii i Alergologii, 36(4), 392–397. https://doi.org/10.5114/ada.2019.87443
13. Tolleson, W. H., Cherng, S. H., Xia, Q., Boudreau, M., Yin, J. J., Wamer, W. G., Howard, P. C., Yu, H., & Fu, P. P. (2005). Photodecomposition and phototoxicity of natural retinoids. International Journal of Environmental Research and Public Health, 2(1), 147–155. https://doi.org/10.3390/ijerph2005010147
14. Melo, M. O., & Maia Campos, P. M. B. G. (2019). Characterization of oily vehicles containing retinyl palmitate: Stability and in vitro release. Journal of Cosmetic Dermatology, 18(5), 1539–1544. https://doi.org/10.1111/jocd.12838
15. Burke, K. E. (2007). Interaction of vitamins C and E as better cosmeceuticals. Dermatologic Therapy, 20(5), 314–321. https://doi.org/10.1111/j.1529-8019.2007.00145.x
16. Shields, C. W., White, J. P., Osta, E. G., & Patel, J. (2020). Physicochemical stability of topical retinoid formulations. Journal of Drugs in Dermatology, 19(4), 407–412. https://pubmed.ncbi.nlm.nih.gov/32310593/
17. Kim, B. H., Lee, Y. S., & Kang, K. S. (2003). The mechanism of retinol-induced irritation and its application to anti-irritant development. Toxicology Letters, 146(1), 65–73. https://doi.org/10.1016/j.toxlet.2003.09.001
18. Esposito, E., Drechsler, M., Mariani, P., Carducci, F., Servadio, M., Melber, C., & Cortesi, R. (2017). Lipid-based nanostructured systems for the topical delivery of retinoids. Pharmaceutics, 9(4), 56. https://doi.org/10.3390/pharmaceutics9040056
19. Nahar, M., Mishra, D., Dubey, V., & Jain, N. K. (2008). Development, characterization, and toxicity evaluation of amphotericin B–loaded gelatin nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine, 4(3), 252–261. https://doi.org/10.1016/j.nano.2008.03.007
20. Carlotti, M. E., Rossatto, V., Gallarate, M., Trotta, M., & Debernardi, F. (2004). Vitamin A palmitate photostability and stability over time. Journal of Cosmetic Science, 55(3), 233–252. https://pubmed.ncbi.nlm.nih.gov/15217175/
21. Coderch, L., López, O., de la Maza, A., & Parra, J. L. (2003). Ceramides and skin function. American Journal of Clinical Dermatology, 4(2), 107–129. https://doi.org/10.2165/00128071-200304020-00004
22. Draelos, Z. D., Matsubara, A., & Smiles, K. (2006). The effect of 2% niacinamide on facial sebum production. Journal of Cosmetic and Laser Therapy, 8(2), 96–101. https://doi.org/10.1080/14764170600717704
23. Gehring, W. (2004). Nicotinic acid/niacinamide and the skin. Journal of Cosmetic Dermatology, 3(2), 88–93. https://doi.org/10.1111/j.1473-2130.2004.00115.x
24. Papakonstantinou, E., Roth, M., & Karakiulakis, G. (2012). Hyaluronic acid: A key molecule in skin aging. Dermato-Endocrinology, 4(3), 253–258. https://doi.org/10.4161/derm.21923
25. Barel, A. O., Paye, M., & Maibach, H. I. (Eds.). (2014). Handbook of Cosmetic Science and Technology (4th ed.). CRC Press. https://doi.org/10.1201/b16716
26. Gorouhi, F., & Maibach, H. I. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science, 31(5), 327–345. https://doi.org/10.1111/j.1468-2494.2009.00490.x
27. Martin, B., Meunier, C., Montels, D., & Bret, L. (1998). Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. British Journal of Dermatology, 139(Suppl. 52), 8–11. https://doi.org/10.1046/j.1365-2133.1998.1390s2008.x
28. Kircik, L. H. (2010). Retinoids and retinoid-combination therapy: Enhancing tolerability. Journal of Drugs in Dermatology, 9(9), s17–s23. https://pubmed.ncbi.nlm.nih.gov/20865799/
29. Bissett, D. L. (2009). Common cosmeceuticals. Clinics in Dermatology, 27(5), 435–445. https://doi.org/10.1016/j.clindermatol.2009.05.006